19, 1469–1472.
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
2014
Vaishnavi, A., Capelletti, M., Le, A.T., Kako, S., Butaney, M., Ercan, D., Mahale, S., Davies, K.D., Aisner, D.L., Pilling, A.B., Berge, E.M., Kim, J., Sasaki, H., Park, S., Kryukov, G., Garraway, L.A., Hammerman, P.S., Haas, J., Andrews, S.W., Lipson, D., Stephens, P.J., Miller, V.A., Varella-Garcia, M., Jänne, P.A. and Doebele, R.C.
Notes: The authors extracted DNA from FFPE or frozen lung cancer samples using the Maxwell® 16 Instrument and the Maxwell® 16 FFPE Plus LEV DNA Kit. Target enrichment was performed, followed by NGS on an Illumina HiSeq 2000 Instrument. (4908)
Expand Full Notes »